MedPath

SYNALAR BI-OTIC SOLUTION

SYNALAR BI-OTIC SOLUTION

Discontinued
DIN Number

00189499

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

medicis canada ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00189499
AIG Number0305644001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S02CA05 FLUOCINOLONE ACETONIDE AND ANTIINFECTIVES
Product Specifications
Dosage FormSolution
Route of AdministrationOtic
AHFS Classification52:04.04
Health Canada Classification

ACTIVE INGREDIENTS (3)

FLUOCINOLONE ACETONIDEActive
Strength: 0.25 MG / ML
Monograph: FLUOCINOLONE ACETONIDE
NEOMYCIN (NEOMYCIN SULFATE)Active
Strength: 3.5 MG / ML
Monograph: NEOMYCIN (NEOMYCIN SULFATE)
POLYMYXIN B SULFATEActive
Strength: 10000 UNIT / ML
Monograph: POLYMYXIN B SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.